Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Blood|September 24, 2005
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocolAntonella Vitale, Anna Guarini, Cristina Ariola, et al.
Haematologica|February 4, 2021
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocolSabina Chiaretti, Michela Ansuinelli, Antonella Vitale, et al.
Blood|September 21, 2011
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaRobin Foà, Antonella Vitale, Marco Vignetti, et al.
American Journal of Hematology|October 7, 2017
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centersSilvia Cantoni, Monica Carpenedo, Maria Gabriella Mazzucconi, et al.
Blood|February 5, 2010
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopeniaFrancesco Zaja, Michele Baccarani, Patrizio Mazza, et al.
Haematologica|May 30, 2008
M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experienceAlessandro Pulsoni, Simona Iacobelli, Massimo Bernardi, et al.
Frontiers in Oncology|December 2, 2022
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experienceRossella Iula, Danilo De Novellis, Fabio Trastulli, et al.
International Journal of Hematology|November 27, 2008
Advanced mast cell disease: an Italian Hematological Multicenter experienceLivio Pagano, Caterina Giovanna Valentini, Morena Caira, et al.
Haematologica|May 30, 2013
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohortsSabina Chiaretti, Antonella Vitale, Gianni Cazzaniga, et al.
The International Journal of Biochemistry & Cell Biology|July 3, 2007
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activitiesPaola Bontempo, Luigi Mita, Marco Miceli, et al.
Pageof 15